{
  "trial_id": "NCT00260143",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Documented weight loss within the previous 6 months of between 5-15% of body weight, or an actual body mass index (BMI) at screening of between 17 and 20 (= 85-95% of the lower limit of ideal weight).",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "An energy intake of at least 80% of the estimated requirements.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "On stable and potent antiretroviral therapy for at least 12 weeks, and in whom, in the opinion of the primary care provider, a change in antiretroviral therapy is unlikely in the next 4 months.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "CD4 cell count >50 /mm3, and HIV-copy number less than 10,000 copies/ml",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Testosterone levels <400ng/dL",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Able and willing to provide informed consent and comply with the protocol",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Does the subject have concurrent severe lipodystrophy according to the subject and the investigator?",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Does the subject have a history of hypersensitivity to anabolic steroids or to growth hormone?",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Does the subject have a history of prostatic or mammary cancer?",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "54",
    "trial_id": "NCT00260143",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}